E. Sahin Hafizoglu Et Al. , "Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors," Current Oncology , vol.33, no.10, 2026
Sahin Hafizoglu, E. Et Al. 2026. Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. Current Oncology , vol.33, no.10 .
Sahin Hafizoglu, E., EKİNCİ, F., ŞAHBAZLAR, M., & ERDOĞAN, A. P., (2026). Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors. Current Oncology , vol.33, no.10.
Sahin Hafizoglu, Ece Et Al. "Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors," Current Oncology , vol.33, no.10, 2026
Sahin Hafizoglu, Ece S. Et Al. "Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors." Current Oncology , vol.33, no.10, 2026
Sahin Hafizoglu, E. Et Al. (2026) . "Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors." Current Oncology , vol.33, no.10.
@article{article, author={Ece Sahin Hafizoglu Et Al. }, title={Lactate Dehydrogenase-to-Albumin Ratio and Glasgow Prognostic Score as Prognostic Markers in Metastatic Breast Cancer Treated with CDK4/6 Inhibitors}, journal={Current Oncology}, year=2026}